The Summary
In a 52-week randomized controlled trial, 193 adults with obesity who achieved initial diet-induced weight loss were assigned to exercise plus placebo, liraglutide alone, combined therapy, or placebo alone. Researchers evaluated physical performance, cardiorespiratory fitness, and muscle strength. While liraglutide alone successfully maintained weight loss, it failed to improve aerobic fitness or functional mobility. In contrast, combining the GLP-1 medication with moderate-to-vigorous exercise significantly enhanced cardiorespiratory fitness and stair-climb speed, while preserving relative muscle strength.
Why this is interesting
Many assume weight loss automatically translates to better physical fitness, but this study proves otherwise. Simply taking a GLP-1 drug like liraglutide helps drop weight but leaves cardiorespiratory endurance and functional performance unchanged. For the reader, this highlights a crucial health reality: to truly boost your heart health, energy, and physical capability while losing weight, exercise remains non-negotiable. Pharmacotherapy helps shrink the body, but active movement is what actually builds and preserves physical vitality.